Remedy Robotics has announced a strategic partnership with the Australian Stroke Alliance to introduce its remotely operated cardiovascular intervention robot to hospitals across Australia. The collaboration marks a major milestone in advancing equitable, timely access to stroke care, particularly for patients in remote and underserved regions.
Under the agreement, the Australian Stroke Alliance has designated Remedy Robotics as its exclusive robotics partner to accelerate the deployment of advanced robotic technology for rapid stroke treatment. The two organizations will work together toward regulatory approvals and national rollout of Remedy’s innovative system, aiming to improve access to endovascular thrombectomy, the current gold standard in ischemic stroke treatment.
Endovascular thrombectomy is a minimally invasive procedure used to remove blood clots from the brain, significantly improving patient outcomes when performed quickly. However, access to this life-saving procedure is currently limited to specialized centers located primarily in major Australian cities.
The partnership seeks to bridge the time and distance gap between stroke onset and intervention by allowing specialists to perform thrombectomies remotely using advanced surgical robotics.
San Francisco–based Remedy Robotics has developed what it calls the world’s first remotely operated endovascular surgical robot. The company’s patented N1 system — backed by 45 patents — enables remote, precision-guided interventions and supports global initiatives to expand access to stroke and cardiovascular procedures. The robotic system was officially unveiled last week.
“Partnering with the Australian Stroke Alliance and their world-leading clinical experts is a major step toward delivering rapid endovascular care to stroke and cardiovascular patients in Australia and worldwide,” said David Bell, CEO and Co-founder of Remedy Robotics. “By combining Remedy’s breakthrough technology with the Alliance’s vision for stroke care, we’re accelerating access to life-saving technology for Australian patients and hospitals. Together, we’re redefining what’s possible in stroke and cardiovascular care when time to treatment is the single most important factor in determining outcomes.”
According to the Stroke Foundation, stroke remains one of Australia’s leading causes of death and disability. With one in four Australians expected to experience a stroke in their lifetime, geographic barriers — especially for rural and Indigenous communities — continue to limit access to specialist stroke care.
“Partnering with Remedy Robotics allows us to reimagine what’s possible and bring expert stroke intervention to people in rural and remote communities, without delay. This collaboration is a major step toward closing disparities in outcomes between rural and urban Australians while saving lives across the continent,” said Professors Stephen Davis AO and Geoffrey Donnan AO, Co-Chairs of the Australian Stroke Alliance.
Through this partnership, Remedy Robotics and the Australian Stroke Alliance aim to transform the stroke treatment landscape by combining clinical expertise and robotic innovation to deliver faster, safer, and more accessible care for all Australians — regardless of geography.